Anti-interleukin-5 and multiple autoantibodies are associated with human atherosclerotic diseases and serum interleukin-5 levels

FASEB Journal

Volumn 27, Issue 9, 2013, Pages 3437-3445

  Ishigami, Tomoaki ^a   Abe, Kaito ^a   Aoki, Ichiro ^a   Minegishi, Shintaro ^a   Ryo, Akihide ^a   Matsunaga, Satoko ^a   Matsuoka, Kazuhiro ^b   Takeda, Hiroyuki ^b   Sawasaki, Tatsuya ^b   Umemura, Satoshi ^a   Endo, Yaeta ^b  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b EHIME UNIVERSITY   (Japan)

Author keywords

Autoimmune; Coronary heart disease; Cytokine; Peripheral artery disease

Indexed keywords

AUTOANTIBODY; CREATININE; GLUCOSE; INTERLEUKIN 5; INTERLEUKIN 5 ANTIBODY; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; ANTIBODY TITER; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HIGH THROUGHPUT SCREENING; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE;

AUTOIMMUNE; CORONARY HEART DISEASE; CYTOKINE; PERIPHERAL ARTERY DISEASE;

AGED; ATHEROSCLEROSIS; AUTOANTIBODIES; CHOLESTEROL, LDL; CORONARY ARTERY DISEASE; FEMALE; HUMANS; INTERLEUKIN-5; MALE; PERIPHERAL ARTERIAL DISEASE;

EID: 84883349820     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.12-222653     Document Type: Article

References (114)

1. Boden, W. E., O'Rourke, R. A., Teo, K. K., Hartigan, P. M., Maron, D. J., Kostuk, W. J., Knudtson, M., Dada, M., Casperson, P., Harris, C. L., Chaitman, B. R., Shaw, L., Gosselin, G., Nawaz, S., Title, L. M., Gau, G., Blaustein, A. S., Booth, D. C., Bates, E. R., Spertus, J. A., Berman, D. S., Mancini, G. B., and Weintraub, W. S. (2007) Optimal medical therapy with or without pci for stable coronary disease. N. Engl. J. Med. 356, 1503-1516
2. Cutlip, D. E., Chhabra, A. G., Baim, D. S., Chauhan, M. S., Marulkar, S., Massaro, J., Bakhai, A., Cohen, D. J., Kuntz, R. E., and Ho, K. K. (2004) Beyond restenosis: Five-year clinical outcomes from second-generation coronary stent trials. Circulation 110, 1226-1230
3. Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., Warren, S. R., Goldman, S., McCarren, M., Vitek, M. E., Henderson, W. G., and Huang, G. D. (2009) Glucose control and vascular complications in veterans with type 2 diabetes. N. Engl. J. Med. 360, 129-139
4. Mihaylova, B., Emberson, J., Blackwell, L., Keech, A., Simes, J., Barnes, E. H., Voysey, M., Gray, A., Collins, R., and Baigent, C. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: Meta-analysis of individual data from 27 randomised trials. Lancet 380, 581-590
5. Kearney, P. M., Blackwell, L., Collins, R., Keech, A., Simes, J., Peto, R., Armitage, J., and Baigent, C. (2008) Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: A meta-analysis. Lancet 371, 117-125
6. Ray, K. K., Seshasai, S. R., Wijesuriya, S., Sivakumaran, R., Nethercott, S., Preiss, D., Erqou, S., and Sattar, N. (2009) Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: A meta-analysis of randomised controlled trials. Lancet 373, 1765-1772
7. Bhatt, D. L., Eagle, K. A., Ohman, E. M., Hirsch, A. T., Goto, S., Mahoney, E. M., Wilson, P. W., Alberts, M. J., D'Agostino, R., Liau, C. S., Mas, J. L., Rother, J., Smith, S. C., Jr., Salette, G., Contant, C. F., Massaro, J. M., and Steg, P. G. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. JAMA 304, 1350-1357
8. Bhatt, D. L., Steg, P. G., Ohman, E. M., Hirsch, A. T., Ikeda, Y., Mas, J. L., Goto, S., Liau, C. S., Richard, A. J., Rother, J., and Wilson, P. W. (2006) International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 295, 180-189
9. Chou, M. Y., Fogelstrand, L., Hartvigsen, K., Hansen, L. F., Woelkers, D., Shaw, P. X., Choi, J., Perkmann, T., Backhed, F., Miller, Y. I., Horkko, S., Corr, M., Witztum, J. L., and Binder, C. J. (2009) Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans. J. Clin. Invest. 119, 1335-1349
10. Hansson, G. K., Libby, P., Schonbeck, U., and Yan, Z. Q. (2002) Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ. Res. 91, 281-291
11. + T cells reactive to modified low-density lipoprotein aggravates atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 26, 864-870
12. Shimada, K. (2009) Immune system and atherosclerotic disease. Circ. J. 73, 994-1001
13. Hansson, G. K. (2009) Atherosclerosis-an immune disease: the Anitschkov lecture 2007. Atherosclerosis 202, 2-10
14. Mallat, Z., Taleb, S., Ait-Oufella, H., and Tedgui, A. (2009) The role of adaptive T-cell immunity in atherosclerosis. J. Lipid Res. 50(Suppl.), S364-S369
15. + T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation 102, 2919-2922
16. Methe, H., Brunner, S., Wiegand, D., Nabauer, M., Koglin, J., and Edelman, E. R. (2005) Enhanced T-helper-1 lymphocyte activation patterns in acute coronary syndromes. J. Am. Coll. Cardiol. 45, 1939-1945
17. Takai, K., Sawasaki, T., and Endo, Y. Practical cell-free protein synthesis system using purified wheat embryos. Nat Protoc 5, 227-238
18. Sawasaki, T., Ogasawara, T., Morishita, R., and Endo, Y. (2002) A cell-free protein synthesis system for high-throughput proteomics. Proc. Natl. Acad. Sci. U. S. A. 99, 14652-14657
19. Sawasaki, T., Gouda, M. D., Kawasaki, T., Tsuboi, T., Tozawa, Y., Takai, K., and Endo, Y. (2005) The wheat germ cell-free expression system: Methods for high-throughput materialization of genetic information. Methods Mol. Biol. 310, 131-144
20. Endo, Y., and Sawasaki, T. (2006) Cell-free expression systems for eukaryotic protein production. Curr. Opin. Biotechnol. 17, 373-380
21. Cho, S., and Kim, E. (2009) CD36: A multi-modal target for acute stroke therapy. J. Neurochem. 109(Suppl. 1), 126-132
22. Matsuoka, K., Komori, H., Nose, M., Endo, Y., and Sawasaki, T. Simple screening method for autoantigen proteins using the N-terminal biotinylated protein library produced by wheat cell-free synthesis. J. Proteome Res. 9, 4264-4273
23. Bowcock, A. M. (2005) The genetics of psoriasis and autoimmunity. Annu. Rev. Genomics Hum. Genet. 6, 93-122
24. Jawaheer, D., Seldin, M. F., Amos, C. I., Chen, W. V., Shigeta, R., Monteiro, J., Kern, M., Criswell, L. A., Albani, S., Nelson, J. L., Clegg, D. O., Pope, R., Schroeder, H. W., Jr., Bridges, S. L., Jr., Pisetsky, D. S., Ward, R., Kastner, D. L., Wilder, R. L., Pincus, T., Callahan, L. F., Flemming, D., Wener, M. H., and Gregersen, P. K. (2001) A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases. Am. J. Hum. Genet. 68, 927-936
25. Cornelis, F., Faure, S., Martinez, M., Prud'homme, J. F., Fritz, P., Dib, C., Alves, H., Barrera, P., de Vries, N., Balsa, A., Pascual-Salcedo, D., Maenaut, K., Westhovens, R., Migliorini, P., Tran, T. H., Delaye, A., Prince, N., Lefevre, C., Thomas, G., Poirier, M., Soubigou, S., Alibert, O., Lasbleiz, S., Fouix, S., Bouchier, C., Liote, F., Loste, M. N., Lepage, V., Charron, D., Gyapay, G., Lopes-Vaz, A., Kuntz, D., Bardin, T., and Weissenbach, J. (1998) New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc. Natl. Acad. Sci. U. S. A. 95, 10746-10750
26. Miyamoto-Sato, E., Ishizaka, M., Horisawa, K., Tateyama, S., Takashima, H., Fuse, S., Sue, K., Hirai, N., Masuoka, K., and Yanagawa, H. (2005) Cell-free cotranslation and selection using in vitro virus for high-throughput analysis of proteinprotein interactions and complexes. Genome Res. 15, 710-717
27. Milburn, M. V., Hassell, A. M., Lambert, M. H., Jordan, S. R., Proudfoot, A. E., Graber, P., and Wells, T. N. (1993) A novel dimer configuration revealed by the crystal structure at 2.4 a resolution of human interleukin-5. Nature 363, 172-176
28. Kinoshita, S., Cohen, K. B., Ogren, P. V., and Hunter, L. (2005) Biocreative task1a: entity identification with a stochastic tagger. BMC Bioinformatics 6(Suppl. 1), S4
29. Tanabe, L., and Wilbur, W. J. (2002) Tagging gene and protein names in biomedical text. Bioinformatics 18, 1124-1132
30. Bek, S., and Kemler, R. (2002) Protein kinase CKII regulates the interaction of beta-catenin with alpha-catenin and its protein stability. J. Cell Sci. 115, 4743-4753
31. Wang, Y., Feng, H., Bi, C., Zhu, L., Pollard, J. W., and Chen, B. (2007) GSK-3beta mediates in the progesterone inhibition of estrogen induced cyclin D2 nuclear localization and cell proliferation in cyclin D1-/- mouse uterine epithelium. FEBS Lett. 581, 3069-3075
32. Huang, W., Chang, H. Y., Fei, T., Wu, H., and Chen, Y. G. (2007) GSK3 beta mediates suppression of cyclin D2 expression by tumor suppressor PTEN. Oncogene 26, 2471-2482
33. Kida, A., Kakihana, K., Kotani, S., Kurosu, T., and Miura, O. (2007) Glycogen synthase kinase-3beta and p38 phosphorylate cyclin D2 on Thr280 to trigger its ubiquitin/proteasomedependent degradation in hematopoietic cells. Oncogene 26, 6630-6640
34. Rosas, M., Dijkers, P. F., Lindemans, C. L., Lammers, J. W., Koenderman, L., and Coffer, P. J. (2006) IL-5-mediated eosinophil survival requires inhibition of GSK-3 and correlates with beta-catenin relocalization. J. Leukoc. Biol. 80, 186-195
35. Min, S. H., Cho, J. S., Oh, J. H., Shim, S. B., Hwang, D. Y., Lee, S. H., Jee, S. W., Lim, H. J., Kim, M. Y., Sheen, Y. Y., and Kim, Y. K. (2005) Tau and GSK3beta dephosphorylations are required for regulating Pin1 phosphorylation. Neurochem. Res. 30, 955-961
36. Umar, S., Wang, Y., Morris, A. P., and Sellin, J. H. (2007) Dual alterations in casein kinase I-epsilon and GSK-3beta modulate beta-catenin stability in hyperproliferating colonic epithelia. Am. J. Physiol. Gastrointest. Liver Physiol. 292, G599-G607
37. Bazzoni, G., Tonetti, P., Manzi, L., Cera, M. R., Balconi, G., and Dejana, E. (2005) Expression of junctional adhesion molecule- A prevents spontaneous and random motility. J. Cell Sci. 118, 623-632
38. Braiman, L., Alt, A., Kuroki, T., Ohba, M., Bak, A., Tennenbaum, T., and Sampson, S. R. (2001) Activation of protein kinase C zeta induces serine phosphorylation of VAMP2 in the GLUT4 compartment and increases glucose transport in skeletal muscle. Mol. Cell. Biol. 21, 7852-7861
39. Fritzius, T., Frey, A. D., Schweneker, M., Mayer, D., and Moelling, K. (2007) WD-repeat-propeller-FYVE protein, ProF, binds VAMP2 and protein kinase Czeta. FEBS J. 274, 1552-1566
40. Lawson, K., Larentowicz, L., Laury-Kleintop, L., and Gilmour, S. K. (2005) B23 is a downstream target of polyamine-modulated CK2. Mol. Cell. Biochem. 274, 103-114
41. Crute, B. E., and Van Buskirk, R. G. (1992) A casein kinase-like kinase phosphorylates beta-tubulin and may be a microtubuleassociated protein. J. Neurochem. 59, 2017-2023
42. Reikhardt, B. A., Kulikova, O. G., Borisova, G. Y., Aleksandrova, I. Y., and Sapronov, N. S. (2003) Status of the "protein kinase CK2-HMG14" system in age-related amnesia in rats. Neurosci. Behav. Physiol. 33, 799-804
43. Jiang, X. G., and Wang, Y. (2006) Phosphorylation of human high mobility group N1 protein by protein kinase CK2.Biochem. Biophys. Res. Commun. 345, 1497-1503
44. Foster, L. J., Yeung, B., Mohtashami, M., Ross, K., Trimble, W. S., and Klip, A. (1998) Binary interactions of the SNARE proteins syntaxin-4, SNAP23, and VAMP-2 and their regulation by phosphorylation. Biochemistry 37, 11089-11096
45. Messenger, M. M., Saulnier, R. B., Gilchrist, A. D., Diamond, P., Gorbsky, G. J., and Litchfield, D. W. (2002) Interactions between protein kinase CK2 and Pin1.Evidence for phosphorylation- dependent interactions. J. Biol. Chem. 277, 23054- 23064
46. Dubois, T., Kerai, P., Learmonth, M., Cronshaw, A., and Aitken, A. (2002) Identification of syntaxin-1A sites of phosphorylation by casein kinase I and casein kinase II. Eur. J. Biochem. 269, 909-914
47. Hao, J. C., Salem, N., Peng, X. R., Kelly, R. B., and Bennett, M. K. (1997) Effect of mutations in vesicle-associated membrane protein (VAMP) on the assembly of multimeric protein complexes. J. Neurosci. 17, 1596-1603
48. Chamberlain, L. H., Burgoyne, R. D., and Gould, G. W. (2001) SNARE proteins are highly enriched in lipid rafts in PC12 cells: implications for the spatial control of exocytosis. Proc. Natl. Acad. Sci. U. S. A. 98, 5619-5624
49. Sun, H. C., Tang, Z. Y., Ma, Z. C., Qin, L. X., Wang, L., Ye, Q. H., Fan, J., Wu, Z. Q., and Zhou, X. D. (2005) The prognostic factor for outcome following second resection for intrahepatic recurrence of hepatocellular carcinoma with a hepatitis B virus infection background. J. Cancer Res. Clin. Oncol. 131, 284-288
50. Perez-Branguli, F., Ruiz-Montasell, B., and Blasi, J. (1999) Differential interaction patterns in binding assays between recombinant syntaxin 1 and synaptobrevin isoforms. FEBS Lett. 458, 60-64
51. Yang, B., Steegmaier, M., Gonzalez, L. C., Jr., and Scheller, R. H. (2000) nSec1 binds a closed conformation of syntaxin1A. J. Cell Biol. 148, 247-252
52. Margittai, M., Otto, H., and Jahn, R. (1999) A stable interaction between syntaxin 1a and synaptobrevin 2 mediated by their transmembrane domains. FEBS Lett. 446, 40-44
53. Poirier, M. A., Hao, J. C., Malkus, P. N., Chan, C., Moore, M. F., King, D. S., and Bennett, M. K. (1998) Protease resistance of syntaxin.SNAP-25.VAMP complexes. Implications for assembly and structure. J. Biol. Chem. 273, 11370-11377
54. Xiao, W., Poirier, M. A., Bennett, M. K., and Shin, Y. K. (2001) The neuronal t-SNARE complex is a parallel four-helix bundle. Nat. Struct. Biol. 8, 308-311
55. Zhang, X., Zhao, M., Huang, A. Y., Fei, Z., Zhang, W., and Wang, X. L. (2005) The effect of cyclin D expression on cell proliferation in human gliomas. J. Clin. Neurosci. 12, 166-168
56. Gutierrez, R., Quiroz-Figueroa, F., and Vazquez-Ramos, J. M. (2005) Maize cyclin D2 expression, associated kinase activity and effect of phytohormones during germination. Plant Cell Physiol. 46, 166-173
57. Huang, T. J., Adcock, I. M., and Chung, K. F. (2001) A novel transcription factor inhibitor, SP100030, inhibits cytokine gene expression, but not airway eosinophilia or hyperresponsiveness in sensitized and allergen-exposed rat. Br. J. Pharmacol. 134, 1029-1036
58. Kim, P. K., Hollerbach, C., Trimble, W. S., Leber, B., and Andrews, D. W. (1999) Identification of the endoplasmic reticulum targeting signal in vesicle-associated membrane proteins. J. Biol. Chem. 274, 36876-36882
59. Hutt, D. M., Da-Silva, L. F., Chang, L. H., Prosser, D. C., and Ngsee, J. K. (2000) PRA1 inhibits the extraction of membranebound rab GTPase by GDI1.J. Biol. Chem. 275, 18511-18519
60. Bucci, C., De Gregorio, L., and Bruni, C. B. (2001) Expression analysis and chromosomal assignment of PRA1 and RILP genes. Biochem. Biophys. Res. Commun. 286, 815-819
61. Martincic, I., Peralta, M. E., and Ngsee, J. K. (1997) Isolation and characterization of a dual prenylated Rab and VAMP2 receptor. J. Biol. Chem. 272, 26991-26998
62. Macaulay, S. L., Hewish, D. R., Gough, K. H., Stoichevska, V., MacPherson, S. F., Jagadish, M., and Ward, C. W. (1997) Functional studies in 3T3L1 cells support a role for SNARE proteins in insulin stimulation of GLUT4 translocation. Biochem. J. 324(Pt. 1), 217-224
63. Chen, G., Liu, P., Thurmond, D. C., and Elmendorf, J. S. (2003) Glucosamine-induced insulin resistance is coupled to O-linked glycosylation of Munc18c. FEBS Lett. 534, 54-60
64. Logan, M. R., Lacy, P., Bablitz, B., and Moqbel, R. (2002) Expression of eosinophil target SNAREs as potential cognate receptors for vesicle-associated membrane 30 protein-2 in exocytosis. J. Allerg. Clin. Immunol. 109, 299-306
65. Saito, T., Okada, S., Yamada, E., Ohshima, K., Shimizu, H., Shimomura, K., Sato, M., Pessin, J. E., and Mori, M. (2003) Syntaxin 4 and Synip (syntaxin 4 interacting protein) regulate insulin secretion in the pancreatic beta HC-9 cell. J. Biol. Chem. 278, 36718-36725
66. Kawanishi, M., Tamori, Y., Okazawa, H., Araki, S., Shinoda, H., and Kasuga, M. (2000) Role of SNAP23 in insulin-induced translocation of GLUT4 in 3T3-L1 adipocytes. Mediation of complex formation between syntaxin4 and VAMP2. J. Biol. Chem. 275, 8240-8247
67. Tellam, J. T., Macaulay, S. L., McIntosh, S., Hewish, D. R., Ward, C. W., and James, D. E. (1997) Characterization of Munc-18c and syntaxin-4 in 3T3-L1 adipocytes. Putative role in insulin-dependent movement of GLUT-4. J. Biol. Chem. 272, 6179-6186
68. Mandon, B., Chou, C. L., Nielsen, S., and Knepper, M. A. (1996) Syntaxin-4 is localized to the apical plasma membrane of rat renal collecting duct cells: possible role in aquaporin-2 trafficking. J. Clin. Invest. 98, 906-913
69. Ke, B., Oh, E., and Thurmond, D. C. (2007) Doc2beta is a novel Munc18c-interacting partner and positive effector of syntaxin 4-mediated exocytosis. J. Biol. Chem. 282, 21786-21797
70. Foran, P. G., Fletcher, L. M., Oatey, P. B., Mohammed, N., Dolly, J. O., and Tavare, J. M. (1999) Protein kinase B stimulates the translocation of GLUT4 but not GLUT1 or transferrin receptors in 3T3-L1 adipocytes by a pathway involving SNAP-23, synaptobrevin-2, and/or cellubrevin. J. Biol. Chem. 274, 28087-28095
71. St-Denis, J. F., and Cushman, S. W. (1998) Role of SNARE's in the GLUT4 translocation response to insulin in adipose cells and muscle. J. Basic Clin. Physiol. Pharmacol. 9, 153-165
72. Widberg, C. H., Bryant, N. J., Girotti, M., Rea, S., and James, D. E. (2003) Tomosyn interacts with the t-SNAREs syntaxin4 and SNAP23 and plays a role in insulin-stimulated GLUT4 translocation. J. Biol. Chem. 278, 35093-35101
73. Takuma, T., Arakawa, T., and Tajima, Y. (2000) Interaction of SNARE proteins in rat parotid acinar cells. Arch. Oral Biol. 45, 369-375
74. Takuma, T., Arakawa, T., Okayama, M., Mizoguchi, I., Tanimura, A., and Tajima, Y. (2002) Trafficking of green fluorescent protein-tagged SNARE proteins in HSY cells. J. Biochem. 132, 729-735
75. Chamberlain, L. H., and Gould, G. W. (2002) The vesicle- and target-SNARE proteins that mediate Glut4 vesicle fusion are localized in detergent-insoluble lipid rafts present on distinct intracellular membranes. J. Biol. Chem. 277, 49750-49754
76. Thurmond, D. C., Ceresa, B. P., Okada, S., Elmendorf, J. S., Coker, K., and Pessin, J. E. (1998) Regulation of insulinstimulated GLUT4 translocation by Munc18c in 3T3L1 adipocytes. J. Biol. Chem. 273, 33876-33883
77. Gougeon, P. Y., Prosser, D. C., Da-Silva, L. F., and Ngsee, J. K. (2002) Disruption of Golgi morphology and trafficking in cells expressing mutant prenylated rab acceptor-1. J. Biol. Chem. 277, 36408-36414
78. Foster, L. J., Weir, M. L., Lim, D. Y., Liu, Z., Trimble, W. S., and Klip, A. (2000) A functional role for VAP-33 in insulinstimulated GLUT4 traffic. Traffic 1, 512-521
79. Weir, M. L., Xie, H., Klip, A., and Trimble, W. S. (2001) VAP-A binds promiscuously to both v- and tSNAREs. Biochem. Biophys. Res. Commun. 286, 616-621
80. Evans, D. T., Tillman, K. C., and Desrosiers, R. C. (2002) Envelope glycoprotein cytoplasmic domains from diverse lentiviruses interact with the prenylated Rab acceptor. J. Virol. 76, 327-337
81. Calero, M., and Collins, R. N. (2002) Saccharomyces cerevisiae Pra1p/Yip3p interacts with Yip1p and Rab proteins. Biochem. Biophys. Res. Commun. 290, 676-681
82. Figueroa, C., Taylor, J., and Vojtek, A. B. (2001) Prenylated Rab acceptor protein is a receptor for prenylated small GTPases. J. Biol. Chem. 276, 28219-28225
83. Lin, J., Liang, Z., Zhang, Z., and Li, G. (2001) Membrane topography and topogenesis of prenylated Rab acceptor (PRA1). J. Biol. Chem. 276, 41733-41741
84. Kurki, S., Peltonen, K., Latonen, L., Kiviharju, T. M., Ojala, P. M., Meek, D., and Laiho, M. (2004) Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation. Cancer Cell 5, 465-475
85. Feuerstein, N. (1991) Phosphorylation of numatrin and other nuclear proteins by cdc2 containing CTD kinase cdc2/p58.J. Biol. Chem. 266, 16200-16206
86. Lehrich, R. W., and Forrest, J. N., Jr. (1994) Protein kinase C zeta is associated with the mitotic apparatus in primary cell cultures of the shark rectal gland. J. Biol. Chem. 269, 32446- 32450
87. Palvimo, J., and Maenpaa, P. H. (1988) Binding of highmobility- group proteins HMG 14 and HMG 17 to DNA and histone H1 as influenced by phosphorylation. Biochim. Biophys. Acta 952, 172-180
88. Espel, E., Bernues, J., Querol, E., Martinez, P., Barris, A., and Lloberas, J. (1983) Interaction between histone H1 and nonhistone HMG14 detected by chemical cross-linking. Biochem. Biophys. Res. Commun. 117, 817-822
89. Wang, C. C., Shi, H., Guo, K., Ng, C. P., Li, J., Gan, B. Q., Chien Liew, H., Leinonen, J., Rajaniemi, H., Zhou, Z. H., Zeng, Q., and Hong, W. (2007) VAMP8/endobrevin as a general vesicular SNARE for regulated exocytosis of the exocrine system. Mol. Biol. Cell 18, 1056-1063
90. Wang, C. C., Ng, C. P., Lu, L., Atlashkin, V., Zhang, W., Seet, L. F., and Hong, W. (2004) A role of VAMP8/endobrevin in regulated exocytosis of pancreatic acinar cells. Dev. Cell 7, 359-371
91. Ling, S., Sheng, J. Z., Braun, J. E., and Braun, A. P. (2003) Syntaxin 1A co-associates with native rat brain and cloned large conductance, calcium-activated potassium channels in situ. J. Physiol. 553, 65-81
92. Pabst, S., Hazzard, J. W., Antonin, W., Sudhof, T. C., Jahn, R., Rizo, J., and Fasshauer, D. (2000) Selective interaction of complexin with the neuronal SNARE complex. Determination of the binding regions. J. Biol. Chem. 275, 19808-19818
93. Ohmura-Hoshino, M., Yamamoto, M., Yuki, Y., Takeda, Y., and Kiyono, H. (2004) Non-toxic Stx derivatives from Escherichia coli possess adjuvant activity for mucosal immunity. Vaccine 22, 3751-3761
94. Kreitzer, G., Schmoranzer, J., Low, S. H., Li, X., Gan, Y., Weimbs, T., Simon, S. M., and Rodriguez-Boulan, E. (2003) Three-dimensional analysis of post-Golgi carrier exocytosis in epithelial cells. Nat. Cell Biol. 5, 126-136
95. Godden-Kent, D., Talbot, S. J., Boshoff, C., Chang, Y., Moore, P., Weiss, R. A., and Mittnacht, S. (1997) The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1.J. Virol. 71, 4193-4198
96. Horton, L. E., and Templeton, D. J. (1997) The cyclin box and C-terminus of cyclins A and E specify CDK activation and substrate specificity. Oncogene 14, 491-498
97. Baluchamy, S., and Gopinathan, K. P. (2005) Characterization of a cyclin homolog from Bombyx mori nucleopolyhedrovirus. Virus Res. 108, 69-81
98. De la Paz Sanchez, M., Torres, A., Boniotti, M. B., Gutierrez, C., and Vazquez-Ramo, J. M. (2002) PCNA protein associates to Cdk-A type protein kinases in germinating maize. Plant Mol. Biol. 50, 167-175
99. Duran, A., Rodriguez, A., Martin, P., Serrano, M., Flores, J. M., Leitges, M., Diaz-Meco, M. T., and Moscat, J. (2004) Crosstalk between PKCzeta and the IL4/Stat6 pathway during T-cellmediated hepatitis. EMBO J. 23, 4595-4605
100. Miyashita, H., Uchida, T., Mori, S., Echigo, S., and Motegi, K. (2003) Expression status of Pin1 and cyclins in oral squamous cell carcinoma: Pin1 correlates with Cyclin D1 mRNA expression and clinical significance of cyclins. Oncol. Rep. 10, 1045-1048
101. Esnault, S., Rosenthal, L. A., Shen, Z. J., Sedgwick, J. B., Szakaly, R. J., Sorkness, R. L., and Malter, J. S. (2007) A critical role for Pin1 in allergic pulmonary eosinophilia in rats. J. Allerg. Clin. Immunol. 120, 1082-1088
102. Miyao, Y., Sagae, K., Saetre, R., Matsuzaki, T., and Tsujii, J. (2009) Evaluating contributions of natural language parsers to proteinprotein interaction extraction. Bioinformatics 25, 394-400
103. Chapman, W. W., and Cohen, K. B. (2009) Current issues in biomedical text mining and natural language processing. J. Biomed. Inform. 42, 757-759
104. Binder, C. J., Hartvigsen, K., Chang, M. K., Miller, M., Broide, D., Palinski, W., Curtiss, L. K., Corr, M., and Witztum, J. L. (2004) IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis. J. Clin. Invest. 114, 427-437
105. Takatsu, K., Kouro, T., Nagai, Y. (2009) Interleukin 5 in the link between the innate and acquired immune response. Adv. Immunol. 101, 191-236
106. IBC 50K CAD Consortium (2011) Large-scale gene-centric analysis identifies novel variants for coronary artery disease. PLoS Genet. 7, e1002260
107. + T regulatory cells that suppress autoimmunity. Blood 119, 4441-4450
108. Takatsu, K., Takaki, S., and Hitoshi, Y. (1994) Interleukin-5 and its receptor system: Implications in the immune system and inflammation. Adv. Immunol. 57, 145-190
109. Daugherty, A., Rateri, D. L., and King, V. L. (2004) IL-5 links adaptive and natural immunity in reducing atherosclerotic disease. J. Clin. Invest. 114, 317-319
110. Binder, C. J., Shaw, P. X., Chang, M. K., Boullier, A., Hartvigsen, K., Horkko, S., Miller, Y. I., Woelkers, D. A., Corr, M., and Witztum, J. L. (2005) The role of natural antibodies in atherogenesis. J. Lipid Res. 46, 1353-1363
111. Miller, A. M., Xu, D., Asquith, D. L., Denby, L., Li, Y., Sattar, N., Baker, A. H., McInnes, I. B., and Liew, F. Y. (2008) IL-33 reduces the development of atherosclerosis. J. Exp. Med. 205, 339-346
112. Drachman, D. B. (2003) Autonomic "myasthenia": the case for an autoimmune pathogenesis. J. Clin. Invest. 111, 797-799
113. Binder, C. J., Horkko, S., Dewan, A., Chang, M. K., Kieu, E. P., Goodyear, C. S., Shaw, P. X., Palinski, W., Witztum, J. L., and Silverman, G. J. (2003) Pneumococcal vaccination decreases atherosclerotic lesion formation: Molecular mimicry between streptococcus pneumoniae and oxidized ldl. Nat. Med. 9, 736-743
114. Sampi, M., Ukkola, O., Paivansalo, M., Kesaniemi, Y. A., Binder, C. J., and Horkko, S. (2008) Plasma interleukin-5 levels are related to antibodies binding to oxidized low-density lipoprotein and to decreased subclinical atherosclerosis. J. Am. Coll. Cardiol. 52, 1370-1378